|
|
| Your Roadmap For Efficient Processes | Facing challenges with mRNA integrity? In this video, we reveal essential solutions for enhancing mRNA stability in mRNA manufacturing. Explore our new DTT and Spermidine endonuclease-free chemicals that enhance efficiency and stability. Watch now to discover more! |
|
|
|
|
By Antony Hitchcock, AGH Bioconsulting, and Philip Probert, CPI | Two experts examine the current guidelines and specs for plasmid DNA and question whether our understanding is sufficient. | |
|
|
|
In this segment of an Advancing RNA Live panel discussion, experts from Life Edit Therapeutics, Tune Therapeutics, and University of Sheffield share their perspectives on the role automation and digital tools (i.e., soft sensors, digital twins) can play in helping us better control our manufacturing processes. |
|
|
|
| High-Sensitivity IVT mRNA Analysis | Application Note | Agilent Technologies | Quality analysis of in vitro transcribed (IVT) has become an essential part of biotherapeutic workflows. Discover a high-sensitivity kit made for analyzing IVT mRNA quality to advance your research. |
|
|
|
| Demand More From Your Oligo Synthesizer | Article | Cytiva | The market for oligonucleotide therapeutics is expanding, and the pipeline is diverse. Gain insight into how you can fast-track your molecule's development with verified synthesizers, columns, and scientific support and expertise. |
|
|
|
| Oligonucleotides: Where We Are And Where We Would Like To Go | White Paper | By Troy Voelker, Ph.D., Aliri Bioanalysis | This presentation provides an overview of oligonucleotide bioanalysis's current status and future directions. We will look into the advantages and disadvantages of various bioanalytical techniques. |
|
|
| Development And Optimization Of LNP Formulations | Application Note | KNAUER | The production of lipid nanoparticles (LNPs) is a process that demands robustness, scalability, and reproducibility. Examine the impact of key operational parameters on the efficacy of LNPs. |
|
|
| Study Viral Infection In Resting Human CD4+ T Cells | Application Note | Synthego Corporation | Explore a study proving how synthetic single guide RNAs were used to optimize the editing conditions for resting human CD4+ T cells and maintain high cell viability for several weeks post Nucleofection. |
|
|
|
|
|
.png){kind=logo}
